Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Aims</h3><p>The mechanisms underlying the selective degeneration of motor neurones in amyotrophic lateral sclerosis (ALS) are poorly understood. The aim of this study was to implement spatially resolved RNA‐sequencing in human post‐mortem cortical tissue from an ALS patient harbouring the <i>C9orf72</i> hexanucleotide repeat expansion to identify dysregulated transcripts that may account for differential vulnerabilities of distinct (i) cell types and (ii) brain regions in the pathogenesis of ALS. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Using spatial transcriptomics (ST) we analysed the transcriptome of post‐mortem brain tissue, with spatial resolution down to 100 μm. Validation of these findings was then performed using BaseScope, an adapted, <i>in situ</i> hybridisation technique with single‐transcript single‐cell‐resolution, providing extensive regional and cell‐type specific confirmation of these dysregulated transcripts. The validation cohort was then extended to include multiple post‐mortem brain regions and spinal cord tissue from an extended cohort of <i>C9orf72</i>, sporadic ALS (sALS) and <i>SOD1</i> ALS cases. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>We identified sixteen dysregulated transcripts of proteins that have roles within six disease‐related pathways. Furthermore, these complementary molecular pathology techniques converged to identify two spatially dysregulated transcripts, <i>GRM3</i> and <i>USP47</i>, that are commonly dysregulated across sALS, <i>SOD1</i> and <i>C9orf72</i> cases alike. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>This study presents the first description of ST in human post‐mortem cortical tissue from an ALS patient harbouring the <i>C9orf72</i> hexanucleotide repeat expansion. These data taken together highlight the importance of preserving spatial resolution, facilitating the identification of genes whose dysregulation may in part underlie regional susceptibilities to ALS, crucially highlighting potential therapeutic and diagnostic targets. </p></section>

GRASPS: a simple-to-operate translatome technology reveals omics-hidden disease-associated pathways in TDP-43-related amyotrophic lateral sclerosis

TDP-43-stratified single-cell proteomics of postmortem human spinal motor neurons reveals protein dynamics in amyotrophic lateral sclerosis

Deep Learning Prediction of Ribosome Profiling with Translatomer Reveals Translational Regulation and Interprets Disease Variants

Mis-spliced transcripts generate de novo proteins in TDP-43-related ALS/FTD

Transcriptome-based screening in TARDBP/TDP-43 knock-in motor neurons identifies the NEDD8-activating enzyme inhibitor MLN4924

Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction

A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration

Single-nucleus transcriptome atlas of orbitofrontal cortex in amyotrophic lateral sclerosis with a deep learning-based decoding of alternative polyadenylation mechanisms

Highly variable molecular signatures of TDP-43 loss of function are associated with nuclear pore complex injury in a population study of sporadic ALS patient iPSNs

Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery

TDP-43 loss induces extensive cryptic polyadenylation in ALS/FTD

Creation of de novo cryptic splicing for ALS and FTD precision medicine

Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis

Deep learning modeling of ribosome profiling reveals regulatory underpinnings of translatome and interprets disease variants

Identifying Candidate Genes Associated with Sporadic Amyotrophic Lateral Sclerosis Via Integrative Analysis of Transcriptome-Wide Association Study and Messenger RNA Expression Profile

Proteomics elucidating physiological and pathological functions of TDP-43

RNA aptamer reveals nuclear TDP-43 pathology is an early aggregation event that coincides with STMN-2 cryptic splicing and precedes clinical manifestation in ALS

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6

Comparison of Parallel High-Throughput RNA Sequencing Between Knockout of TDP-43 and Its Overexpression Reveals Primarily Nonreciprocal and Nonoverlapping Gene Expression Changes in the Central Nervous System of Drosophila

TDP-43 pathology links innate and adaptive immunity in amyotrophic lateral sclerosis